KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Bio-Rad Laboratories (BIO) over the last 14 years, with Q4 2025 value amounting to $6.1 billion.

  • Bio-Rad Laboratories' Long-Term Investments rose 2612.83% to $6.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.1 billion, marking a year-over-year increase of 2612.83%. This contributed to the annual value of $6.1 billion for FY2025, which is 2612.83% up from last year.
  • Bio-Rad Laboratories' Long-Term Investments amounted to $6.1 billion in Q4 2025, which was up 2612.83% from $5.1 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Long-Term Investments ranged from a high of $16.2 billion in Q3 2021 and a low of $4.8 billion during Q4 2024
  • Moreover, its 5-year median value for Long-Term Investments was $7.6 billion (2022), whereas its average is $8.2 billion.
  • In the last 5 years, Bio-Rad Laboratories' Long-Term Investments skyrocketed by 9325.67% in 2021 and then plummeted by 5404.27% in 2022.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Long-Term Investments stood at $14.4 billion in 2021, then plummeted by 38.62% to $8.8 billion in 2022, then decreased by 12.83% to $7.7 billion in 2023, then tumbled by 37.14% to $4.8 billion in 2024, then increased by 26.13% to $6.1 billion in 2025.
  • Its Long-Term Investments was $6.1 billion in Q4 2025, compared to $5.1 billion in Q3 2025 and $5.6 billion in Q2 2025.